Welcome to LookChem.com Sign In|Join Free
  • or
2-Aminopurine, also known as 2-AP, is an organic compound and a derivative of the purine family. It is characterized by a purine core with an amino substituent at the 2-position. This white to light yellow crystal powder has unique chemical properties that make it a versatile molecule for various applications in different fields.

452-06-2

Post Buying Request

452-06-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

452-06-2 Usage

Uses

Used in Biochemistry and Molecular Biology:
2-Aminopurine is used as a probe for studying structural dynamics and charge transfer in DNA. Its incorporation into DNA allows researchers to monitor and analyze the behavior of DNA molecules under different conditions, providing valuable insights into the molecular mechanisms of genetic processes.
Used in Pharmaceutical Research:
In the field of pharmaceutical research, 2-Aminopurine is used as an inhibitor of eukaryotic initiation factor-2α (eIF2α)-phosphorylation in osteoarthritis (OA) chondrocytes. This application helps in understanding the role of eIF2α in the development and progression of osteoarthritis, potentially leading to the development of novel therapeutic strategies for the treatment of this condition.

Biochem/physiol Actions

2-Aminopurine (2AP) is an analog of guanosine and adenosine, which can base pair with cytosine and thymine. It is used as a fluorescent probe in nucleic acid structure and dynamics. 2-Aminopurine (2-AP) inhibits double-stranded RNA-dependent protein kinase, protein kinase R (PKR).

Safety Profile

Mutation data reported. Whenheated to decomposition it emits toxic fumes of NOx.

Check Digit Verification of cas no

The CAS Registry Mumber 452-06-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,5 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 452-06:
(5*4)+(4*5)+(3*2)+(2*0)+(1*6)=52
52 % 10 = 2
So 452-06-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H5N5/c6-5-7-1-3-4(10-5)9-2-8-3/h1-3H,(H2,6,8,9,10)

452-06-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A1111)  2-Aminopurine  >98.0%(HPLC)(T)

  • 452-06-2

  • 200mg

  • 1,290.00CNY

  • Detail
  • TCI America

  • (A1111)  2-Aminopurine  >98.0%(HPLC)(T)

  • 452-06-2

  • 1g

  • 4,730.00CNY

  • Detail
  • USP

  • (1269130)  FamciclovirRelatedCompoundE  United States Pharmacopeia (USP) Reference Standard

  • 452-06-2

  • 1269130-25MG

  • 13,501.80CNY

  • Detail

452-06-2Synthetic route

2-(methylthio)-9H-purine
33512-51-5

2-(methylthio)-9H-purine

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With potassium amide In ammonia for 70h; Mechanism; 2-halogenated purines;90%
2-Amino-6-chloropurin
10310-21-1

2-Amino-6-chloropurin

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
In hydrogenchloride at 50℃; electrolysis, -0.75V, initial current 50-60 mA;85%
palladium on charcoal In sodium hydroxide; water
1,2-diaminopurinium mesitylenesulphonate

1,2-diaminopurinium mesitylenesulphonate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With methylamine In methanol at 100℃; for 17h;80%
1,2-diaminopurinium mesitylenesulphonate

1,2-diaminopurinium mesitylenesulphonate

A

purine
120-73-0

purine

B

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With ammonia In methanol at 100℃; for 17h; Mechanism; Product distribution;A 70%
B 20%
pyrimidine-2,4,5-triamine
3546-50-7

pyrimidine-2,4,5-triamine

dimethoxymethyl acetate
14036-53-4

dimethoxymethyl acetate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
1.) RT, 6 h, 2.) reflux, 30 min;61%
1-amino-2-(methylthio)purinium mesitylenesulfonate

1-amino-2-(methylthio)purinium mesitylenesulfonate

A

2-(methylthio)-9H-purine
33512-51-5

2-(methylthio)-9H-purine

B

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With ammonia In methanol at 100℃; for 17h; Product distribution; Mechanism; ANRORC and no ANRORC mechanism determined by reaction with 15N labelled ammonia; var. temp. and time;A 55%
B 25%
amipurimycin
61991-08-0

amipurimycin

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With trifluoroacetic acid at 130℃;48%
6-(2-acetylvinylthio)-2-aminopurine

6-(2-acetylvinylthio)-2-aminopurine

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With nickel In water for 7.5h; Heating;35.7%
iso-2',3'-dideoxyadenosine
107550-74-3

iso-2',3'-dideoxyadenosine

A

2,3-Didesoxy-β-D-glycero-pentofuranose
122999-44-4

2,3-Didesoxy-β-D-glycero-pentofuranose

B

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With hydrogenchloride at 22℃; rate of hydrolysis relative to dideoxyadenosine;
2-amino-9-(β-D-2'-deoxyribofuranosyl)-purine
3616-24-8

2-amino-9-(β-D-2'-deoxyribofuranosyl)-purine

A

2,4-diamino-5-formamidopyrimidine
18620-60-5

2,4-diamino-5-formamidopyrimidine

B

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
With sodium cacodylate buffer; water at 110℃; for 22h; Kinetics; Thermodynamic data; Mechanism; ΔH(excit.); var. temp. and times;
thioguanine
154-42-7

thioguanine

9H-purin-2-amine
452-06-2

9H-purin-2-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 60 percent / NaOH / dioxane; H2O / 5 - 10 °C
2: 35.7 percent / Raney nickel / H2O / 7.5 h / Heating
View Scheme
Conditions
ConditionsYield
With Canyon Diablo iron meteorites at 140℃; for 24h; Reagent/catalyst; Temperature;
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-aminopurine thallium salt

2-aminopurine thallium salt

Conditions
ConditionsYield
With thallium (I) ethoxide In ethanol at 15 - 20℃; for 36h;92%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2'-deoxy-2'-fluorouridine
56287-17-3, 69123-94-0, 784-71-4

2'-deoxy-2'-fluorouridine

2-amino-9-(2-deoxy-2-fluoro-β-D-ribofuranosyl)-9H-purine

2-amino-9-(2-deoxy-2-fluoro-β-D-ribofuranosyl)-9H-purine

Conditions
ConditionsYield
In water at 37℃; for 48h; thymidine phosphorylase, purine nucleoside phosphorylase, phosphate buffer, pH 7;89%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2'-Deoxycytidine
951-77-9

2'-Deoxycytidine

2-amino-9-(β-D-2'-deoxyribofuranosyl)-purine
3616-24-8

2-amino-9-(β-D-2'-deoxyribofuranosyl)-purine

Conditions
ConditionsYield
With citrate buffer; N-deoxyribosyltransferase from L. leichmannii In ethanol at 40℃; for 48h;86%
tert-butyl 4-bromobutyrate
110661-91-1

tert-butyl 4-bromobutyrate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

C13H19N5O2
1043904-91-1

C13H19N5O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 50 - 80℃;85%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

1,2:5,6-dianhydro-3,4-di-O-benzyl-L-iditol
157363-84-3

1,2:5,6-dianhydro-3,4-di-O-benzyl-L-iditol

1-(2-amino-9H-purin-9-yl)-2,5-anhydro-3,4-di-O-benzyl-1-deoxy-D-glucitol

1-(2-amino-9H-purin-9-yl)-2,5-anhydro-3,4-di-O-benzyl-1-deoxy-D-glucitol

Conditions
ConditionsYield
Stage #1: 9H-purin-2-amine With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 2h;
Stage #2: 1,2:5,6-dianhydro-3,4-di-O-benzyl-L-iditol In N,N-dimethyl-formamide at 110℃;
66%
sodium phenyl-methanolate
20194-18-7

sodium phenyl-methanolate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

N-(phenylmethyl)-aminopurine

N-(phenylmethyl)-aminopurine

Conditions
ConditionsYield
at 130℃; for 17h;63%
mesitylenesulfonylhydroxylamine
36016-40-7

mesitylenesulfonylhydroxylamine

9H-purin-2-amine
452-06-2

9H-purin-2-amine

1,2-diaminopurinium mesitylenesulphonate

1,2-diaminopurinium mesitylenesulphonate

Conditions
ConditionsYield
In methanol; dichloromethane for 4h; Ambient temperature;62%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-amino-9-(β-D-arabinofuranosyl)purine

2-amino-9-(β-D-arabinofuranosyl)purine

Conditions
ConditionsYield
With phosphate buffer; cell paste of Enterobacter aerogenes AJ 11125 at 60℃; for 15h; pH 7.0;61%
4-acetoxy-3-(acetoxymethyl)-1-iodobutane
127047-77-2

4-acetoxy-3-(acetoxymethyl)-1-iodobutane

9H-purin-2-amine
452-06-2

9H-purin-2-amine

A

7-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
131266-15-4

7-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

B

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide for 18h; Ambient temperature;A 15%
B 59%
tert-butyl prop-2-ynoate
13831-03-3

tert-butyl prop-2-ynoate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

A

C12H15N5O2
1043904-89-7

C12H15N5O2

B

C12H15N5O2
1043904-90-0

C12H15N5O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 50 - 80℃;A 57%
B 23%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

cis/trans-1-acetoxymethyl-2-bromo-2-(bromomethyl)cyclopropane

cis/trans-1-acetoxymethyl-2-bromo-2-(bromomethyl)cyclopropane

A

(Z,E)-2-amino-7-[(2-acetoxymethyl)cyclopropylidenemethyl]purine

(Z,E)-2-amino-7-[(2-acetoxymethyl)cyclopropylidenemethyl]purine

B

(Z,E)-2-amino-9-[(2-acetoxymethyl)cyclopropylidenemethyl]purine

(Z,E)-2-amino-9-[(2-acetoxymethyl)cyclopropylidenemethyl]purine

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide at 20 - 65℃; for 8h;A 20%
B 53%
ethyl bromoacetate
105-36-2

ethyl bromoacetate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-(2-amino-9H-purin-9-yl)acetic acid
933477-63-5

2-(2-amino-9H-purin-9-yl)acetic acid

Conditions
ConditionsYield
Stage #1: 9H-purin-2-amine With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 1h; Inert atmosphere;
Stage #2: ethyl bromoacetate In N,N-dimethyl-formamide for 2h; Inert atmosphere;
Stage #3: With sodium hydroxide In water; N,N-dimethyl-formamide at 20℃; for 1h; Inert atmosphere;
51%
(5aS,7S)-7-[(1R/S)-2-bromo-1-methylethyl]-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran
1134003-26-1

(5aS,7S)-7-[(1R/S)-2-bromo-1-methylethyl]-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran

9H-purin-2-amine
452-06-2

9H-purin-2-amine

(5aS,7S)-7-[(1R/S)-2-(2-amino-9H-purin-9-yl)-1-methylethyl]-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran
1134003-03-4

(5aS,7S)-7-[(1R/S)-2-(2-amino-9H-purin-9-yl)-1-methylethyl]-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran

Conditions
ConditionsYield
Stage #1: 9H-purin-2-amine With caesium carbonate In N,N-dimethyl-formamide at 25℃; for 1h; Inert atmosphere;
Stage #2: (5aS,7S)-7-[(1R/S)-2-bromo-1-methylethyl]-3-methyl-1H,7H-5a,6,8,9-tetrahydro-1-oxopyrano[4,3-b][1]benzopyran In N,N-dimethyl-formamide at 25℃; for 24h; Inert atmosphere;
48%
5-chloromethyl-2,2-dimethyl-1,3-dioxolane
4362-40-7

5-chloromethyl-2,2-dimethyl-1,3-dioxolane

9H-purin-2-amine
452-06-2

9H-purin-2-amine

A

9-(RS)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl-2-aminopurine
120139-11-9

9-(RS)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl-2-aminopurine

B

7-(RS)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl-2-aminopurine
120139-12-0

7-(RS)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl-2-aminopurine

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 100℃; for 14h;A 44%
B 15%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2',3'-Dideoxyuridine
5983-09-5

2',3'-Dideoxyuridine

iso-2',3'-dideoxyadenosine
107550-74-3

iso-2',3'-dideoxyadenosine

Conditions
ConditionsYield
at 50℃; for 2h; Escherichia coli JA-300 cells, pH 6.5;44%
Diethyl 2-Bromoethoxymethanephosphonate
116384-57-7

Diethyl 2-Bromoethoxymethanephosphonate

9H-purin-2-amine
452-06-2

9H-purin-2-amine

[2-(2-Amino-purin-9-yl)-ethoxymethyl]-phosphonic acid diethyl ester
126354-35-6

[2-(2-Amino-purin-9-yl)-ethoxymethyl]-phosphonic acid diethyl ester

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide a) At 80 deg C for 1 h 2) addition of IIc,80 deg C for 16 h;40%
diethyl-2-(2-bromoethylidene)malonte
51385-79-6

diethyl-2-(2-bromoethylidene)malonte

9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-amino-9-(2,2-dicarboethoxycyclopropyl)purine
134470-59-0

2-amino-9-(2,2-dicarboethoxycyclopropyl)purine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide39%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

5-(chloromethyl)-1,2,3-trimethoxybenzene
3840-30-0

5-(chloromethyl)-1,2,3-trimethoxybenzene

9-(3,4,5-trimethoxybenzyl)-9H-purin-2-ylamine

9-(3,4,5-trimethoxybenzyl)-9H-purin-2-ylamine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 70℃; for 4h;36%
9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-deoxy-2-fluoro-α-D-arabinofuranose 1-phosphate
850883-62-4

2-deoxy-2-fluoro-α-D-arabinofuranose 1-phosphate

2-Amino-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purine

2-Amino-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purine

Conditions
ConditionsYield
purine nucleoside phosphorylase In water at 50℃; for 216h; pH=7.5; Aqueous phosphate buffer; Enzymatic reaction;32%
acetic anhydride
108-24-7

acetic anhydride

9H-purin-2-amine
452-06-2

9H-purin-2-amine

2-(N-acetylamino)purine
23567-61-5

2-(N-acetylamino)purine

Conditions
ConditionsYield
With ethanol 1) EtOH, 25 min, reflux, 2) 15 min, reflux; Yield given. Multistep reaction;

452-06-2Relevant academic research and scientific papers

Meteorites as catalysts for prebiotic chemistry

Saladino, Raffaele,Botta, Giorgia,Delfino, Michela,Di Mauro, Ernesto

, p. 16916 - 16922 (2014/01/06)

From outer space: Twelve meteorite specimens, representative of their major classes, catalyse the synthesis of nucleobases, carboxylic acids, aminoacids and low-molecular-weight compounds from formamide (see figure). Different chemical pathways are identified, the yields are high for a prebiotic process and the products come in rich and composite panels.

Synthesis and degradation of nucleic acid components by formamide and iron sulfur minerals

Saladino, Raffaele,Neri, Veronica,Crestini, Claudia,Costanzo, Giovanna,Graciotti, Michele,Di Mauro, Ernesto

experimental part, p. 15512 - 15518 (2009/03/12)

We describe the one-pot synthesis of a large panel of nucleic bases and related compounds from formamide in the presence of iron sulfur and iron-copper sulfur minerals as catalysts. The major products observed are purine, 1H-pyrimidinone, isocytosine, adenine, 2-aminopurine, carbodiimide, urea, and oxalic acid. Isocytosine and 2-aminopurine may recognize natural nucleobases by Watson-Crick and reverse Watson-Crick interactions, thus suggesting novel scenarios for the origin of primordial nucleic acids. Since the major problem in the origin of informational polymers is the instability of their precursors, we also investigate the effects of iron sulfur and iron-copper sulfur minerals on the stability of ribooligonucleotides in formamide and in water. All of the iron sulfur and iron-copper sulfur minerals stimulated degradation of RNA. The relevance of these findings with respect to the origin of informational polymers is discussed.

Nucleoside analogue phosphates for topical use

-

, (2008/06/13)

Compositions for topical use in herpes virus infections comprising anti-herpes nucleoside analogue phosphate esters, such as acyclovir monophosphate, acyclovir diphosphate, and acyclovir triphosphate which show increased activity against native strains of herpes virus as well as against resistant strains, particularly thymidine kinase negative strains of virus. Also disclosed are methods for treatment of herpes infections with nucleoside phosphates. Anti-herpes nucleoside analogues phosphate esters include the phosphoramidates and phosphothiorates, as well as polyphosphates comprising C and S bridging atoms.

4'-substituted nucleosides

-

, (2008/06/13)

Nucleosides compounds of Formula I: STR1 wherein B is a purine or a pyrimidine; X and X' are H; Y is H; Y' is OH, F or H; or Y' and X' together makes a bond; Z is STR2 where n is zero, one, two or three; or Y' and Z together form a cyclic phosphate ester; Z' is --CN, --CH3, CH2 N3 or --CH2 J, where J is a halogen atom; or Z' and Y' together are --CH2 O--; and pharmaceutically acceptable esters, ethers, amides, N-acyl moieties and salts thereof.

Artificial DNA base pair analogues

-

, (2008/06/13)

The present invention is directed to new artificial base pairs comprising complementary artificial purines and pyrimidines and methods of using artificial complementary base pairs.

Catalytic hydrogenation of 2-amino-6-chloropurine

-

, (2008/06/13)

A process for the preparation of a compound of formula (I): STR1 which process comprises the reduction of a compound of formula (II): STR2 by catalytic hydrogenation using palladium on charcoal as catalyst.

Hydrolysis of 2-Aminopurine Deoxyribonucleoside in Neutral Solution

Ratsep, Peter C.,Pless, Reynaldo C.

, p. 3241 - 3246 (2007/10/02)

At various temperatures between 50 and 110 deg C, 2-aminopurine deoxyribonucleoside is severalfold more prone to degradation in aqueous sodium cacodylate buffer, pH 6.9, than is its structural isomer, deoxyadenosine, as determined by HPLC analysis of hydrolysates.It is calculated that, at 37 deg C, the rate of hydrolysis of 2-aminopurine deoxyribonucleoside is 5 times as large as the rate of hydrolysis of deoxyadenosine.The decomposition of 2-aminopurine deoxyribonucleoside is almost unaffected by changes in ionic strength or buffer concentration, but is clearly accelerated by increasing acidity in the range from pH 5.8 to pH 7.15.While deoxyadenosine decomposes to produce the corresponding free base, adenine, as the sole UV-absorbing product, 2-aminopurine deoxyribonucleoside yields primarily 2,4-diamino-5-formamidopyrimidine rather than 2-aminopurine.The latter compound is also formed during hydrolysis of 2-aminopurine deoxyribonucleoside, but it arises largely in a secondary reaction from 2,4-diamino-5-formamidopyrimidine.The increased propensity to depurination evinced by 2-aminopurine deoxyribonucleoside in comparison to deoxyadenosine as well as the alteration of the heterocyclic base occurring during the hydrolysis is of interest in view of the mutagenic activity of 2-aminopurine.

A 15N-STUDY ON THE DEAMINATION OF 1-AMINOPURINIUM SALTS WITH AMINES

Kos, Nico J.,Jongejan, Hugo,Plas, Henk C. van der

, p. 369 - 374 (2007/10/02)

Reaction of 1-aminoadenosinium mesitylenesulphonate, 1a, with methanolic ammonia for 10 h at 80 deg C yields adenosine, 7a, and nebularine, 6a.With methanolic methylamine 1a gives 6-methylamino-9-β-D-ribofuranosylpurine, 8a, and adenosine, 7a, respectively.Similar results are obtained with the salt of 1-amino-2',3'-O-isopropylideneadenosine, 1b. 1-Aminoadeninium mesitylenesulphonate, 1c, with methanolic methylamine only yields 6-(methylamino)purine, 8c.In contrast, the mesitylenesulphonate salt of 1,2-diaminopurine, 11, with methanolic methylamine gives only deamination at N1, affording 2-aminopurine, 12.Studies with 15N-labelled methanolic ammonia or 15N-labelled purinium compounds show that in all these reactions, except that of 11, a ring-opening mechanism (ANRORC-mechanism) is involved.

Preparative electrochemical reduction of 2-amino-6-chloropurine and synthesis of 6-deoxyacyclovir, a fluorescent substrate of xanthine oxidase and a prodrug of acyclovir.

Kusmierek,Czochralska,Johansson,Shugar

, p. 701 - 707 (2007/10/02)

D.c. polarography of 2-amino-6-chloropurine in aqueous medium over a broad pH range revealed two diffusion waves, the first of which corresponds to reduction of the C(6)-Cl bond, leading to formation of 2-aminopurine in high yield. Condensation of the sodium salt of 2-aminopurine with (2-acetoxyethoxy)methyl chloride led to the two isomeric 9- and 7-(2-hydroxyethoxymethyl)-2-aminopurines. The 9- isomer, 6-deoxyacyclovir, a prodrug of acyclovir previously synthesized by another route, was readily converted to the latter by xanthine oxidase; the 7-isomer was not a substrate. The intense fluorescence of 6-deoxyacyclovir makes it a convenient fluorescent substrate for xanthine oxidase, although less sensitive than xanthine; it is shown that 2-aminopurine would be a very sensitive fluorescent substrate. The polarographic behaviour of the riboside of 2-amino-6-chloropurine was virtually identical with that of the parent purine, leading to a simple procedure for conversion of 2-amino-6-chloropurine nucleosides and acyclonucleosides to the corresponding 2-aminopurine congeners.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 452-06-2